Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) EBT Margin (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed EBT Margin for 10 consecutive years, with 461.0% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, EBT Margin changed N/A year-over-year to 461.0%, compared with a TTM value of 1920.4% through Sep 2025, changed N/A, and an annual FY2024 reading of 2078.3%, changed N/A over the prior year.
  • EBT Margin was 461.0% for Q4 2024 at Lisata Therapeutics, down from 244729.41% in the prior quarter.
  • Across five years, EBT Margin topped out at 461.0% in Q4 2024 and bottomed at 461.0% in Q4 2024.